研究業績 Our Publications

和文総説および著書はこちら

原著論文

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 〜2006

2024

• Horiuchi M, Watanabe S, Komine O, Takahashi E, Kaneko K, Itohara S, Shimada M, Ogi T, Yamanaka K: ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice. Acta Neuropathologica Communications 12: 184, 2024.
  名古屋大学からのプレスリリース
• Sobue A, Komine O, Endo F, Kakimi C, Miyoshi Y, Kawade N, Watanabe S, Saito Y, Murayama S, Saido SC, Saito T, Yamanaka K: Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation. Cell Death & Diseaae 15: 858, 2024.
  名古屋大学からのプレスリリース
• Fujisawa H, Watanabe T, Komine O, Fuse S, Masaki M, Iwata N, Murao N, Seino Y, Takeuchi H, Yamanaka K, Sawada M, Suzuki A, Sugimura Y: Prolonged extracellular low sodium concentrations and subsequent their rapid correction modulate nitric oxide production dependent on NFAT5 in microglia. Free Radical Biology and Medicine 147: 84, 2024.
• Leventoux N, Morimoro S, Ishikawa M, Nakamura S, Ozawa F, Kobayashi R, Watanabe H, Supakul S, Okamoto S, Zhou Z, Kobayashi H, Kato C, Hirokawa Y, Aiba I, Takahashi S, Shibata S, Takao M, Yoshida M, Endo F, Yamanaka K, Kokubo Y, Okano H: Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes. Acta Neuropathologica 147: 84, 2024.
• Watanabe S, Amporndanai K, Awais R, Latham C, Awais M, O'Neill PM, Yamanaka K, Hasnain S: Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement. Scientific Reports 14, 12118, 2024.
• Wang T, Sobue A, Watanabe S, Komine O, Saido TC, Saito T, Yamanaka K: Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease. Journal of Neuroinflammation 21(1), 55, 2024.
• Komine O, Ohnuma S, Hinohara K, Hara Y, Shimada M, Akashi T, Watanabe S, Sobue A, Kawade N, Ogi T, Yamanaka K: Genetic background variation impacts microglial heterogeneity and disease progression in amyotrophic lateral sclerosis model mice. iScience 27(2), 108872, 2024.
  名古屋大学からのプレスリリース

2023

• Watanabe S, Murata Y, Oka Y, Oiwa K, Horiuchi M, Iguchi Y, Komine O, Sobue A, Katsuno M, Ogi T, Yamanaka K: Mitochondria-associated membrane collapse impairs TBK1-mediated proteostatic stress response in ALS. Proceedings of the National Academy of Sciences of the United States of America 120(47): e2315347120, 2023.
  名古屋大学からのプレスリリース
• Adachi K, Miyata K, Chiba Y, Hirose M, Morisaki Y, Yamanaka K, Misawa H: Depletion of perivascular macrophages delays ALS disease progression by ameliorating blood-spinal cord barrier impairment in SOD1G93A mice. Frontiers in Cellular Neuroscience 17: 1291673, 2023.
• Hirayama T, Shibukawa M, Morioka H, Hozumi M, Tsuda H, Atsuta N, Izumi Y, Nakayama Y, Shimizu T, Inoue H, Urushitani M, Yamanaka K, Aoki M, Ebihara S, takeda A, Kano O: The necessity to improve disaster preparedness among patients with amyotrophic lateral sclerosis and their families. Journal of Clinical Neuroscience 116: 87-92, 2023.
• Oiwa K, Watanabe S, Onodera K, Iguchi Y, Kinoshita Y, KOmine O, Sobue A, Okada Y, Katsuno M, Yamanaka K: Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis. Science Advances 9(31): eadf6895, 2023.
  名古屋大学からのプレスリリース
• Kawade N, Yamanaka K: Novel insights into brain lipid metabolism in Alzheimer's disease: Oligodendrocytes and white matter abnormalities. FEBS Open Bio 14(2): 194-216, 2023.
• Matsudaira T, Nakano S, Konishi Y, Kawamoto S, Uemura K, Kondo T, Sakurai K, Ozawa T, Hikida T, Komine O, Yamanaka K, Fujita Y, Yamashita T, MatsumotoT, Hara E: Cellular senescence in white matter microglia is induced during ageing in mice and exacerbates the neuroinflammatory phenotype. Communications Biology 665, 2023.
• Hashimoto K, Watanabe S, Akutu M, Mukai N, Kamishina H, Furukawa Y, Yamanaka K: Intrinsic structural vulnerability in the hydrophobic core induces species-specific aggregation of canine SOD1 with degenerative myelopathy–linked E40K mutation. Journal of Biological Chemistry 299(6): 104798, 2023.
  名古屋大学からのプレスリリース
• Sobue A, Komine O, Yamanaka K: Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease. Inflammation & Regeneration 43: 26, 2023.
• Maekawa K, Yamanaka K: Role of sex hormones in neuroinflammation in Alzheimer's disease. Clinical & Experimental Neuroimmunology 4: 16 1045647, 2023.
• Watanabe S, Horiuchi M, Murata Y, Komine O, Kawade N, Sobue A, Yamanaka K: Sigma-1 receptor maintains ATAD3A as a monomer to inhibit mitochondrial fragmentation at the mitochondria-associated membrane in amyotrophic lateral sclerosis. Neurobiology of Disease 2: 179 106031, 2023.
  名古屋大学からのプレスリリース

2022

• Yamashita H, Komine O, Fujimori-Tonou, N, Yamanaka K: Comprehensive expression analysis with cell-type-specific transcriptome in ALS-linked mutant SOD1 mice: Revisiting the active role of glial cells in disease. Frontiers in Cellular Neuroscience 4: 16 1045647, 2022.
• Hirayama T, Shibukawa M, Yanagihashi M, Warita H, Atsuta N, Yamanaka K, Kano O: Investigation of non-motor symptoms in patients with amyotrophic lateral sclerosis. Acta Neurologica Belgica 123(5): 1797-1804, 2022.

2021

• Sakai S, Watanabe S, Komine O, Sobue A, and Yamanaka K: Novel reporters of mitochondria-associated membranes (MAM), MAMtrackers, demonstrate MAM disruption as a common pathological feature in amyotrophic lateral sclerosis. FASEB Journal e21688, 2021.
  
• Sobue A, Komine O, Hara Y, Endo F, Mizoguchi H, Watanabe S, Murayama S, Saito T, Saido T, Sahara N, Higuchi M, Ogi T and Yamanaka K: Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer’s disease. Acta Neuropathologica Communications 9: 1, 2021.
  名古屋大学からのプレスリリース
• Hirose M, Asano M, Watanabe-Matsumoto S, Yamanaka K, Abe Y, Yasui M, Tokuda E, Furukawa Y, Misawa H: Stagnation of glymphatic interstitial fluid flow and delay in waste clearance in the SOD1-G93A mouse model of ALS. Neuroscience Research 171: 74-82, 2021.

2020

• Saifullah MAB, Komine O, Dong Y, Fukumoto K, Sobue A, Endo F, Saito T, Saido TC, Yamanaka K, Mizoguchi H: Touchscreen-based location discrimination and paired associate learning tasks detect cognitive impairment at an early stage in an App knock-in mouse model of Alzheimer's disease. Molecular Brain 13: 147, 2020.
  名古屋大学からのプレスリリース
• Watanabe S, Inami H, Oiwa K, Murata Y, Sakai S, Komine O, Sobue A, Iguchi Y, Katsuno M, Yamanaka K: Aggresome formation and liquid–liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43. Cell Death & Disease 11: 909, 2020.
  名古屋大学からのプレスリリース
• Konishi H, Okamoto T, Hara Y, Komine O, Tamada H, Maeda M, Osako F, Kobayashi M, Nishiyama A, Kataoka Y, Takai T, Udagawa N, Jung S, Ozato K, Tamura T, Tsuda M, Yamanaka K, Ogi T, Sato K, Kiyama H: Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunction. EMBO Journal 22: e104464, 2020.
  名古屋大学からのプレスリリース
• Amporndanai K, Rogers M, Watanabe S, Yamanaka K, O’Neill P. M., Hasnain S. S.: Novel Selenium-based compounds with therapeutic potential for SOD1-linked Amyotrophic Lateral Sclerosis. EBioMedicine 59: 102980, 2020.
  名古屋大学からのプレスリリース
• Sugiyama M, Banno R, Yaginuma H, Taki K, Mizoguchi A, Tsunekawa T, Onoue T, Takagi H, Ito Y, Iwama S, Goto M, Suga H, Komine O, Yamanaka K, Arima H: Hypothalamic glial cells isolated by MACS reveal that microglia and astrocytes induce hypothalamic inflammation via different processes under high-fat diet conditions. Neurochemistry International 136: 104733, 2020.
• Nakazawa Y, Hara Y, Oka Y, Komine O, van den Heuvel D, Guo C, Daigaku Y, Isono M, He Y, Shimada M, Kato K, Jia N, Hashimoto S, Kotani Y, Miyoshi Y, Tanaka M, Sobue A, Mitsutake N, Suganami T, Masuda A, Ohno K, Nakada S, Mashimo T, Yamanaka K, Luijsterburg MS, Ogi T: Ubiquitination of DNA Damage-Stalled RNAPII Promotes Transcription-Coupled Repair. Cell 180(6): 1228-1244.e24, 2020.
• Watanabe S, Oiwa K, Murata Y, Komine O, Sobue A, Endo F, Takahashi E and Yamanaka K: ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration. Molecular Brain 13: 8, 2020.

2019

• Nishino K, Watanabe S, Shijie J, Murata Y, Oiwa K, Komine O, Endo F, Tsuiji H, Abe M, Sakimura K, Mishra A, Yamanaka K: Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1-Akt signaling pathway. Acta Neuropathologica Communications 7(1): 118, 2019.
• Trias E, Barbeito L, Yamanaka K: Phenotypic heterogeneity of astrocytes in motor neuron disease. Clinical Experimantal Neurology 9(4): 225-234, 2018.

2018

• Komine O, Yamashita H, Fujimori-Tonou N, Koike M, Jin S, Moriwaki Y, Endo F, Watanabe S, Uematsu S, Akira S, Uchiyama Y, Takahashi R, Misawa H, Yamanaka K: Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes. Cell Death & Differentiation 25: 2130-2146, 2018.
  名古屋大学からのプレスリリース
• Tokuda E, Nomura T, Ohara S, Watanabe S, Yamanaka K, Morisaki Y, Misawa H, Furukawa Y: A copper-deficient form of mutant cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis. Biochimica et Biophysica Acta 1864(6): 2119-2130, 2018.

2017

• Watanabe S, Komine O, Fumito E, Wakasugi K, Yamanaka K: Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1-linked amyotrophic lateral sclerosis mice. Journal of Neurochemistry 145(1): 80-89, 2017.
• Watanabe-Matsumoto S, Moriwaki Y, Okuda T, Ohara S, Yamanaka K, Abe Y, Yasui M, Misawa H: Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis. Neuroscience Research 133: 480-57, 2017.
• Yamanaka K, Komine O: The multi-dimensional roles of astrocytes in ALS. Neuroscience Research 126: 31-38, 2018.
• Tsuiji H, Inoue I, Takeuchi M, Furuya A, Yamakage Y, Watanabe S, Koike M, Hattori M, Yamanaka K: TDP-43 accelerates age-dependent degeneration of interneurons. Scientific Reports 7: 14972, 2017.
  
• Yamasaki T, Deki-Arima N, Kaneko A, Miyamura N, Iwatsuki M, Matsuoka M, Fujimori-Tonou N, Okamoto-Uchida Y, Hirayama J, Marth JD, Yamanashi Y, Kawasaki H, Yamanaka K, Penninger JM, Shibata S, Nishina H: Age-dependent motor dysfunction due to neuron-specific disruption of stress-activated protein kinase MKK7. Scientific Reports 7: 7348, 2017.
• Tokuda E, Anzai I, Nomura T, Toichi K, Watanabe M, Ohara S, Watanabe S, Yamanaka K, Morisaki Y, Misawa H, Furukawa Y: Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis. Molecular Neurodegeneration 12: 2, 2017.

2016

• Endo F, Komine O, Yamanaka K: Neuroinflammation in motor neuron disease. Clinical and Experimental Neuroimmunology 7: 126-138, 2016.
• Watanabe S, Ilieva H, Tamada H, Nomura H, Komine O, Endo F, Jin S, Mancias P, Kiyama H, Yamanaka K: Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Molecular Medicine 8(12): 1421-1437, 2016.
  
• Anzai I, Tokuda E, Mukaiyama A, Akiyama S, Endo F, Yamanaka K, Misawa H, Furukawa Y: A misfolded dimer of Cu/Zn-superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis. Protein Science 26(3): 484-496, 2016.
• Amanullah A, Upadhyay A, Chhangani D, Joshi V, Mishra R, Yamanaka K, Mishra A: Proteasomal Dysfunction Induced by Diclofenac Engenders Apoptosis Through Mitochondrial Pathway. Journal of Cellular Biochemistry 118(5): 1014-1027, 2016.
• Morisaki Y, Niikura M, Watanabe M, Onishi K, Tanabe S, Moriwaki Y, Okuda T, Ohara S, Murayama S, Takao M, Uchida S, Yamanaka K, Misawa H: Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9. Scientific Reports 6: 27354, 2016.
• Lasiene J, Komine O, Fujimori-Tonou N, Powers B, Endo F, Watanabe S, Shijie J, Ravits J, Horner P, Misawa H, Yamanaka K: Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Acta Neuropathologica Communications 4: 15, 2016
  

2015

• Chhangani D, Endo F, Amanullah A, Upadhyay A, Watanabe S, Mishra R, *Yamanaka K, Mishra A: Mahogunin ring finger 1 confers cytoprotection against mutant SOD1 aggresomes and is defective in an ALS mouse model. Neurobiology of Disease 86: 16, 2015.
  
• Komine O & Yamanaka K: Neuroinflammation in motor neuron disease. Nagoya Journal of Medical Science 77: 537, 2015.
• Endo F & Yamanaka K: Astrocytic TGF-β1: detrimental factor in ALS. Oncogene 6: 15728, 2015.
• Endo F, Komine O, Fujimori-Tonou N, Katsuno M, Jin S, Watanabe S, Sobue G, Dezawa M, Wyss-Coray T, *Yamanaka K: Astrocyte-derived TGF-β1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Reports 11: 592, 2015.
  
• Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP: Neuroinflammation in Alzheimer’s disease. Lancet Neurology 14: 388, 2015.

2014

• Watanabe S, Hayakawa T, Wakasugi K, *Yamanaka K: Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity. Cell Death & Disease, 5: e1497, 2014.
• Watanabe S, Ageta-Ishihara N, Nagatsu S, Takao K, Komine O, Endo F, Miyakawa T, Misawa H, Takahashi R, Kinoshita M, *Yamanaka K: SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system. Molecular Brain 7: 62, 2014.
  
• Austin JA, Wright GS, Watanabe S, Grossmann JG, Antonyuk SV, Yamanaka K, Hasnain SS: Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proceedings of the Natural Academy of Sciences, USA 111: 4309-4314, 2014.
• Nomura T, Watanabe S, Kaneko K, Yamanaka K, Nukina N, Furukawa Y: Intranuclear Aggregation of Mutant FUS/TLS as a Molecular Pathomechanism of Amyotrophic Lateral Sclerosis. The Journal of Biological Chemistry, 289: 1192-1202, 2014.

2013

• Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N: Intracellular seeded aggregation of mutant Cu,Zn-superoxide dismutase associated with amyotrophic lateral sclerosis. FEBS Letters 587: 2500-2505, 2013.
• Iguchi Y, Katsuno M, Niwa J, Takagi S, Ishigaki S, Ikenaka K, Kawai K, Watanabe H, Yamanaka K, Takahashi R, Misawa H, Sasaki S, Tanaka F, Sobue G: Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain, 136: 1371-1382, 2013.
• Toichi K, Yamanaka K, Furukawa Y: Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis. The Journal of Biological Chemistry, 288: 4970-4980, 2013.
• Tsuiji H, Iguchi Y, Furuya A, Kataoka A, Hatsuta H, Atsuta N, Tanaka F, Hashizume Y, Akatsu H, Murayama S, Sobue G, *Yamanaka K: Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Molecular Medicine, 5: 221-234, 2013.
  

2012

• Watanabe S, Kaneko K, *Yamanaka K: Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked TDP-43 mutations. The Journal of Biological Chemistry, 288: 3641-3654, 2012.
  理化学研究所からのプレスリリース
• Mishra A, Maheshwari M, Chhangani D, Fujimori-Tonou N, Endo, F, Joshi AP, Jana NR, *Yamanaka K. E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity. Neurobiology of Aging, 34: 1310.e11-23, 2012.

2011

• Lasiene J, *Yamanaka K: Glial cells in Amyotrophic Lateral Sclerosis. Neurology Research International 2011: 718987, 2011.
• Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, Li H, Zhou Y, Mori R, Yasuoka S, Li E, Parajuli B, Kawanokuchi J, Sonobe Y, Sato J, Yamanaka K, Sobue G, Mizuno T, Suzumura A: Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease. PLoS ONE, 6(6): e21108, 2011.
• Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N: A seeding reaction recapitulates intracellular formation of sarkosyl-insoluble TAR DNA binding protein-43 inclusions. The Journal of Biological Chemistry, 286: 18664-18672, 2011.

2010

• Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, Clevalend DW: Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS. Neuron, 67: 575-587, 2010.
• Furukawa Y, Kaneko K, Yamanaka K, Nukina N: Mutation-dependent polymorphism of Cu, Zn-superoxide dismutase aggregates in the familial form of amyotrophic lateral sclerosis. The Journal of Biological Chemistry, 285: 22221-22231, 2010.

2009

• Lobsiger CS, Boillee S, McAlonis-Downes M, Khan AM, Feltri ML, Yamanaka K, Cleveland DW: Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proceedings of the Natural Academy of Sciences, USA, 106:4465-4470, 2009.
  理化学研究所からのプレスリリース
• Cleveland DW, Yamanaka K, Bomont P: Gigaxonin controls vimentin organization through tubulin chaperone-independent pathway. Human Molecular Genetics, 18:1384-1394, 2009.

2008

• Ilieva H, Yamanaka K, Malkmus S, Kakinohana O, Yaksh T, Marsala M, Cleveland DW: Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proceedings of the Natural Academy of Sciences, USA, 105: 12599-12604, 2008.
• Yamanaka K, Boillee S, Roberts EA, Garcia ML, McAlonis-Downes M, Mikse OR, Cleveland DW, Goldstein LSB: Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proceedings of the Natural Academy of Sciences, USA, 105: 7594-7599, 2008.
• Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW: Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience, 11: 251-253, 2008.
  Highlighted as a “Fast Breaking Paper” by Thomson Reuter (2009.4)
  
• Furukawa Y, Kaneko K, Yamanaka K, O’Halloran, TV, Nukina N: Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in familial form of ALS. The Journal of Biological Chemistry 283: 24167-24176, 2008.

2007

• Yamashita H, Kawamata J, Okawa K, Kanki R, Nakamizo T, Hatayama T, Yamanaka K, Takahashi R, Shimohama S: Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide　dismutase; clues to a possible strategy for treating ALS. Journal of Neurochemistry, 102: 1497-1505, 2007.

2006年以前 (抜粋)

• Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW: Onset and Progression in Inherited ALS determined by Motor Neurons and Microglia. Science, 312: 1389-1392, 2006. # Co-first authors
• Miller TM, Kim SH, Yamanaka K, Hester M, Umapathi P, Arnson H, Rizo L, Mendell JR, Gage FH, Cleveland DW, Kaspar BK: Gene transfer demonstrates that muscle is not a primary target for non-cell autonomous toxicity in familial amyotrophic lateral sclerosis. Proceedings of the Natural Academy of Sciences, USA, 103: 19546-19551, 2006.
• Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei H, Wancewicz EV, Bennett CF, Cleveland DW: Antisense Oligonucleotides as a Therapy for Neurodegenerative diseases. Journal of Clinical Investments, 116: 2290-2296, 2006.
• Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW: Progressive axonal degeneration and slowness in ALS2-deficient mice. Annals of Neurology, 60: 95-104, 2006.
• Eymard-Pierre E, Yamanaka K, Haeussler M, Kress W, Gauthier-Barichard F, Combes P, Cleveland DW, Boespflug-Tanguy O: Novel Missense Mutation in ALS2 gene results in Infantile Ascending Hereditary Spastic Paralysis. Annals of Neurology, 59: 976-980, 2006.
• Miller TM, Kaspar BK, Kops GJ, Yamanaka K, Christian LJ, Gage FH, Cleveland DW: Virus-delivered siRNA preserves strength in ALS mice. Annals of Neurology, 57: 773-776, 2005.
• Yamanaka K, Vande Velde C, Eymard-Pierre E, Bertini E, Boespflug-Tanguy O, Cleveland DW: Unstable mutants in the peripheral endosomal membrane component ALS2 cause early onset motor neuron disease. Proceedings of the Natural Academy of Sciences, USA, 100: 16041-16046, 2003.
• Yamanaka K, Ishikawa H, Megumi Y, Tokunaga F, Kanie M, Rouault TA, Morishima I, Minato N, Ishimori K, Iwai K: Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nature Cell Biology 5: 336-340, 2003.
• Bertini E, Eymard-Pierre E, Boespflug-Tanguy O, Cleveland DW, Yamanaka K: ALS2-Related Disorders. In: GeneReviews at GeneTests: Medical Genetics Information Resource. Copyright, University of Washington, Seattle. 2005. Revised in 2011. Available at http://www.genetests.org. (peer-reviewed online review)
• Yamanaka K, Cleveland DW: Determinants of rapid disease progression in ALS. Neurology, 65: 1859-1860, 2005.

和文総説・著書など

• 渡邊 征爾, 酒井 昭平, 山中 宏二: ER-ミトコンドリアコンタクトサイトの定量と観察（第6章-2） 実験医学別冊「疾患研究につながるオルガネラ実験必携プロトコール」 2024.
• 堀内 麻衣, 山中 宏二 : グリア細胞の関与. ALS-どこまでわかり、どこまで治るか Clinical Neuroscience (月刊 臨床神経科学) 41(3), 357-360, 2023.
• 大岩 康太郎, 山中 宏二 : 筋萎縮性側索硬化症とグリア　脳神経内科 207-212, 2022.
• 川出 野絵, 山中 宏二 : ミクログリアと神経変性疾患 実験医学増刊 「シン・マクロファージ」 40(5): 132-137, 2022.
• 山中 宏二 : ミクログリアと神経変性疾患 実験医学増刊 「神経免疫 メカニズムと疾患」 39(15): 109-114, 2021.
• 祖父江 顕, 山中 宏二 : マクロファージの功罪 - 疾患病態誘導と制御におけるマクロファージの役割 医学のあゆみ 273(10): 975-979, 2020.
• 小峯 起, 山中 宏二 : 筋萎縮性側索硬化症, 前頭側頭型認知症と炎症. 老年精神医学雑誌 31(7): 723-729, 2020.
• 遠藤 史人, 山中 宏二 : 神経変性疾患と免疫性神経疾患 -ALSを中心に- 日本臨床 免疫性神経疾患 update 78(11): 1824-1831, 2020.
• Yamanaka K: Chapter 3 - Animal models for neurodegenerative disorders. Animal Biotechnology (2nd edition) 43-61, 2020.
• 山中 宏二, 祖父江 顕 : ミクログリアと神経炎症 別冊 Bio Clinica 慢性炎症と疾患 9(2): 66-70, 2020.
• 渡邊 征爾, 山中 宏二 : 筋萎縮性側索硬化症におけるMAMの破綻 実験医学 37(12): 138-144, 2019.
• 渡邊 征爾, 山中 宏二 : 第7回 筋萎縮性側索硬化症(ALS) 和光純薬時報 86(4): 18-20, 2018.
• Hitomi Tsuiji, Koji Yamanaka : Animal Models for Neurodegenerative Disorders. In:Verma A, Singh A, editors. Animal Biotechnology: Models in Discovery and Translation, Elsevier, pp39-56, 2014.
• 遠藤史人, 山中宏二 : 筋萎縮性側索硬化症におけるグリア病態・神経炎症 医学のあゆみ 248(12): 901-906, 2014.
• 山中宏二 : 炎症と神経変性.（企画） 医学のあゆみ 248(12): 879-911, 2014.
• 山下博史，山中宏二 : ALS病態におけるグリアの役割.　脳21 15(1): 28-33, 2012.
• 山中宏二 : ALS におけるグリア関連病態.　臨床神経学 51: 1192-1194, 2011.
• 山下博史, 山中宏二 : ALS-SOD1の発症機序. Clinical Neuroscience 29: 1044-1045, 2011.
• 山中宏二 : 神経変性疾患における細胞死研究のパラダイムシフト. 実験医学 別冊　羊土社, 2010, p1188-1194.
• 山中宏二, 遠藤史人: ALSの病態—非細胞自律性の神経細胞死. 医学のあゆみ　235: 241-245, 2010.
• 山中宏二 : ALSの今後の研究方向と可能性は. MB Medical Rehabilitation 113: 13-18, 2009.
• 山中宏二 : 筋萎縮性側索硬化症とグリア細胞. Medical Science Digest, 35: 262-263, 2009.
• 山中宏二, 渡辺祥司 : 筋萎縮性側索硬化症: 非細胞自律性の神経細胞死. 神経内科　68: 140-146, 2008.
• 山中宏二 : 筋萎縮性側索硬化症の動物モデル.　臨床神経学 47: 934-937,2007.
• 山中宏二, 山下博史 : ALSとミクログリア―非細胞自律性の神経細胞死.　Brain and Nerve 59:1163-1170, 2007.
• 山中宏二 : ALS研究のトピックスー非細胞自律性の神経細胞死 実験医学増刊 「脳神経疾患の分子病態と治療への展開」 109-114, 2007.
• 山中宏二 : ALSの発症と進行は運動ニューロンとミクログリアが規定する. 実験医学　24: 2509-2512, 2006.